aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Nexeption, LLC is a biopharmaceutical management company focused on integrating product opportunities, management expertise, and funding to achieve significant partnership milestones. The company specializes in raising capital, operating development-stage companies, and forming strategic alliances to advance products for patient benefit.
Nexeption's management team has a proven track record in the biopharmaceutical industry, successfully securing investments and forging strategic partnerships. Their efforts have significantly impacted the advancement of various biopharmaceutical products, enhancing patient care and treatment options.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private
Main Product(s)
Biopharmaceuticals
Tags
Biotech
Model Types
Professional Services
Revenue Type(s)
Consulting
Customer Type(s)
Enterprise
Geographic Exposure
United States
When was Nexeption founded?
Nexeption was founded in 2013.
Where is Nexeption's headquarters located?
Nexeption's headquarters is located in Wayne, PA, US.
When was Nexeption's last funding round?
Nexeption's most recent funding round was for $21.5M (USD) in January 2014.
How many employees does Nexeption have?
Nexeption has 14 employees as of Feb 4, 2024.
How much has Nexeption raised to-date?
As of July 05, 2023, Nexeption has raised a total of $21.5M (USD) since Jan 2, 2014.
Add Comparison
Total Raised to Date
$21.5M
USD
Last Update Jan 2, 2014
Last Deal Details
$21.5M
USD
Jan 2, 2014
Series A
Total Employees Over Time
14
As of Feb 2024
Nexeption Address
640 Lee Rd
Wayne,
Pennsylvania
19087
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts